Keyphrases
Hepatitis B Virus
100%
Chronic Hepatitis B
100%
Therapeutic Vaccination
100%
Woodchuck
100%
Immunomodulation
100%
Antiviral Treatment
66%
Hepatitis B Virus Infection
66%
Nucleos(t)ide Analogues
66%
Therapeutic Vaccine
66%
Commercially Available
33%
Interferon-α (IFN-α)
33%
Vaccination
33%
Programmed Death-ligand 1 (PD-L1)
33%
Large Region
33%
Recombinant Viral Vectors
33%
Virus-specific T Cells
33%
Hepatitis B
33%
Hepatitis B Vaccine
33%
Liver Disease
33%
Chronic Hepatitis
33%
Chronic Hepatitis B Virus
33%
Hepatitis B Carrier
33%
Immune Control
33%
Viral Load
33%
Virus Persistence
33%
Woodchuck Hepatitis Virus
33%
Prime-boost Vaccination
33%
Acute Hepatitis
33%
New Therapeutic Approaches
33%
Immunostimulatory
33%
Virus-like
33%
Innovative Strategies
33%
Strategies to Overcome
33%
Mother-to-child Transmission
33%
Hepadnaviral Infection
33%
DNA Vaccine
33%
Marmota Monax
33%
Innovative Approach
33%
Preclinical Animal Models
33%
Woodchuck Model
33%
Recommended Treatment
33%
Pre-vaccination Era
33%
Pharmacology, Toxicology and Pharmaceutical Science
Preclinical Study
100%
Immunomodulation
100%
Woodchuck
100%
Hepatitis B Virus
100%
Chronic Hepatitis B
100%
Therapeutic Vaccine
33%
Antivirus Agent
33%
Hepatitis B
33%
Hepadnavirus Infection
16%
Infection
16%
Liver Disease
16%
Adenovirus Vector
16%
Chronic Hepatitis
16%
Virus Carrier
16%
Persistent Virus Infection
16%
Virus Vaccine
16%
Acute Hepatitis
16%
Programmed Death 1 Receptor
16%
Interferon
16%
Woodchuck Hepatitis Virus
16%
DNA Immunization
16%
Immunology and Microbiology
Immunomodulation
100%
Hepatitis B Virus
100%
Preclinical Study
100%
Woodchuck
100%
Hepatitis B
100%
Interferon Type I
16%
Viral Load
16%
Virus
16%
Immunity
16%
Adenovirus Vector
16%
Virus Carrier
16%
Programmed Death 1 Receptor
16%
Virus Vaccine
16%
T Cell
16%
Woodchuck Hepatitis Virus
16%
DNA Immunization
16%